Bioventix (BVXP) AGM Report

Report by Roger Lawson

After the euphoria of a sweeping Conservative election victory, at least for stock market investors, it’s back to more humdrum business. Here’s a report on the Annual General Meeting of Bioventix (BVXP) which was held yesterday.

Bioventix is the developer of antibodies used in medical diagnostics. It’s a small company with only 12 employees but revenue was up 16% last year to £9.3 million and EPS up by 3.7%.

Talking to CEO Peter Harrison before the meeting, he indicated there would be

Click here for the complete AGM report if you are a full member of ShareSoc, as these reports are exclusive to our full members. The above is only an introduction to the full report, which contains much more information. Further information about access to our AGM reports can be found here.